Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and misrepresented the health of its gross margins while downplaying existing issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][2]. Allegations - The complaint alleges that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [1]. - It is claimed that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively affected the company's gross margins and overall financial results [1]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying existing issues [1]. - As a result, the public statements made by the defendants are considered materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from May 30, 2024, to February 6, 2025, and shareholders are encouraged to register by June 3, 2025, to participate [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies engage in responsible business practices and good corporate citizenship [3].

Group 1 - Cronos (NASDAQ: CRON) reported increasing revenues and net income for Q1-2025, with both international and domestic sales on the rise [1] - The company's stock has increased by 25% over the last month and is up 6.5% since the last coverage in March [1] - The report is part of a monthly analysis on the cannabis industry, highlighting the analyst's expertise in technical stock analysis and emerging markets [1]

Core Insights - Ayurcann Holdings Corp. reported record-breaking financial results for the three months ended March 31, 2025, showcasing exceptional growth and operational excellence in the cannabis industry [1][2] Financial Performance - Gross revenue for Q3 2025 reached $14,179,974, marking a 22% year-over-year increase from $11,655,360 in Q3 2024 [8] - Positive adjusted EBITDA of $766,742 at the operating subsidiary level and $342,634 on a consolidated basis, with a gross margin of 38% [8] - Consistent gross margins and a disciplined cost structure support sustainable profitability and future shareholder value [6] Market Position - Ayurcann is recognized as a Top 3 vape producer in Ontario by volume, holding a 5% share of the national vape market and an 8% share in Ontario [8] - The company has established itself as one of Canada's most efficient and scalable cannabis producers, with strong market share and growing brand recognition [8] Product Development and Expansion - Over the last six months, Ayurcann launched 25 new SKUs across vapes, pre-rolls, and concentrates, enhancing its product portfolio [8] - The company is actively expanding into additional provinces and retail channels across Canada, which is expected to drive continued revenue growth [7][8] - Ayurcann is scaling its pre-rolls and concentrates to tap into growing consumer segments in the cannabis market [8] Operational Efficiency - The company's lean, high-throughput manufacturing model enables it to maintain strong gross margins and positive cash flow in a competitive pricing environment [8] - Ayurcann's products are now available nationwide, positioning the company as a reliable national supplier to retailers [8]

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that it will be reporting its financial results for the three months ended March 31, 2025 (“Q1 2025”) after market close on Tuesday, May 27, 2025. The Company will be hosting a conference call to discuss Q1 2025 results on Wednesday, ...

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) is providing this update on the status of a management cease trade order granted on May 1, 2025 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203"). On May 1, 2025, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying manag ...

Financial Data and Key Metrics Changes - Total net sales for Q2 fiscal 2025 were $4.7 million, representing an 8.6% increase year-over-year but a 7.9% decrease from Q1 [14] - Gross profit margin remained healthy at 62% for Q2 fiscal 2025, despite increased warehouse rent and one-time CAM costs [15] - SG&A expenses decreased to $3.5 million in Q2 fiscal 2025 from $4.1 million in the prior year, primarily due to reductions in payroll and professional fees [15][16] - The net loss for Q2 fiscal 2025 was $480,000, significantly improved from a loss of $3 million in the same quarter of the previous year [16] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales were flat year-over-year at $3.6 million, accounting for 77% of total net sales, down from 83% in the prior year [14] - Wholesale revenue increased by 22% to $1.1 million in Q2 fiscal 2025 compared to $750,000 in the same quarter of the previous year [15] Market Data and Key Metrics Changes - The THC seltzer category is experiencing significant growth, with sales projected to exceed $4 billion by 2028, driven by a shift in consumer preferences towards functional social alternatives [11] Company Strategy and Development Direction - The company aims to drive revenue growth and achieve profitability while resolving its capital structure and regaining compliance with NYSE American listing standards [5] - The successful conversion of Series A preferred stock into common stock and the reverse stock split are seen as major milestones that simplify the capital structure and eliminate legacy obligations [6][7] - The company is focused on three revenue growth priorities: enhancing the direct-to-consumer business, expanding the wholesale business, and scaling the Herbal Oasis brand [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to adapt to regulatory changes and emphasized the importance of regulatory clarity for the long-term success of the THC seltzer category [12] - The company is committed to delivering profitable growth in 2025 and is evaluating strategic opportunities for mergers and acquisitions [19][20] Other Important Information - The company reported cash and cash equivalents of approximately $1.7 million and a working capital deficit of $3.7 million as of March 31, 2025 [17] - The company invested approximately $400,000 in inventory during the quarter to bolster key SKUs and support the rollout of the Herbal Oasis brand [18] Q&A Session Summary Question: Update on Herbal Oasis brand expansion - Management indicated that discussions with distributors began in December, with shipments starting in March and April, and further expansion into Charlotte announced in May [25][30] Question: Expectations for Herbal Oasis as a growth driver - Management expects to see contributions from the Herbal Oasis brand toward the end of 2025, with potential for material impact on top-line revenue [30] Question: Impact of preferred to common stock conversion on strategy - The conversion enhances financial flexibility and positions the company to maintain its NYSE listing, allowing for strategic investments and M&A opportunities [31][33] Question: Working capital and cash burn outlook - Management remains comfortable with the liquidity outlook through the end of fiscal 2026, despite recent cash burn trends [39][40] Question: Types of strategic activities being considered - Management is looking for opportunities that provide cost synergies and customer overlap, both within and outside the cannabinoid space [42][44]

Financial Data and Key Metrics Changes - Total net sales for Q2 2025 were $4.7 million, representing an 8.6% increase year-over-year but a 7.9% decrease from Q1 2025 [13] - Gross profit margin remained healthy at 62% for Q2 2025, despite increased warehouse rent and one-time CAM costs [14] - SG&A expenses decreased to $3.5 million in Q2 2025 from $4.1 million in the prior year, primarily due to reductions in payroll and professional fees [15] - The net loss for Q2 2025 was approximately $480,000, significantly improved from a loss of $3 million in Q2 2024 [15] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales were flat year-over-year at $3.6 million, accounting for 77% of total net sales in Q2 2025, down from 83% in the prior year [13] - Wholesale revenue increased by 22% to $1.1 million in Q2 2025 compared to $750,000 in Q2 2024 [14] - The company is focusing on three revenue growth priorities: enhancing direct-to-consumer business, expanding wholesale, and scaling the Herbal Oasis brand [8][10] Market Data and Key Metrics Changes - The THC seltzer category is experiencing significant growth, with sales projected to exceed $4 billion by 2028 [10] - The company is tracking active legislation in over 23 states, which is crucial for the long-term success of the THC seltzer category [11] Company Strategy and Development Direction - The company aims to drive revenue growth and achieve profitability while resolving its capital structure [5] - The successful conversion of Series A preferred stock and the reverse stock split are seen as major milestones for long-term positioning [6] - The company is exploring strategic opportunities, including M&A, to expand into new categories and customer segments [19][42] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to adapt to regulatory changes and emphasized a commitment to profitable growth in 2025 [19][21] - The company believes it is in a stronger position than many public peers, with no debt and a low cash burn rate [21] - Management is optimistic about the potential contributions from the Herbal Oasis brand in the latter half of 2025 [30] Other Important Information - The company has approximately $1.7 million in cash and cash equivalents, with a working capital deficit of $3.7 million as of March 31, 2025 [16] - The capital restructuring has simplified the capital structure, making the stock more investable and increasing interest from potential investors [20] Q&A Session Summary Question: Expansion plans for Herbal Oasis brand - Management indicated that discussions with distributors began in December, and shipments have started, with expectations for growth contributions by the end of 2025 [25][30] Question: Impact of preferred to common equity conversion on strategy - The conversion enhances financial flexibility and positions the company to maintain its NYSE listing, allowing for potential strategic investments [31][33] Question: Working capital situation and cash burn outlook - Management remains comfortable with the liquidity outlook through the end of fiscal 2026, aiming for improved cash generation [39][40] Question: Types of strategic activities being considered - The company is looking for opportunities that provide cost synergies and customer overlap, both within and outside the cannabinoid space [42][44] Question: Financial performance metrics for Herbal Oasis - Revenue impact from Herbal Oasis was minimal in Q2 but is expected to pick up in Q3, with a focus on volume contribution [45]

Core Insights - cbdMD, Inc. reported continued revenue growth and a trend towards profitability in the second fiscal quarter of 2025, with a revenue increase to $4.8 million from $4.3 million year-over-year [2][3] - The company successfully completed a capital structure reset through the conversion of Series A Preferred Stock, adding nearly $7 million to its equity base and achieving compliance with NYSE American listing standards [3][4] Financial Performance - Revenue for the second quarter reached $4.8 million, reflecting an increase of 11.6% compared to the prior year [2] - Operating loss narrowed significantly from $1.5 million to $0.48 million, indicating improved expense management and early success from growth initiatives [2][4] - Gross margin improved from 59% to 62% year-over-year during the second quarter [8] - Net loss attributable to common shareholders decreased to approximately $1.48 million, or $1.90 per share, compared to a net loss of approximately $4.0 million, or $10.84 per share, in the prior year [8][18] Capital Structure and Compliance - The Series A Preferred conversion on May 7, 2025, eliminated $6.7 million in accrued dividend liability and added equivalent equity value, positioning the company with a clean balance sheet and zero debt [3][4] - The company executed an 8:1 reverse stock split, resulting in approximately 8.9 million common shares outstanding as of May 15, 2025 [8] Strategic Developments - The Herbal Oasis beverage brand expanded distribution into Alabama, Florida, and North Carolina, tapping into a rapidly growing wellness category [4] - All four flavors of Herbal Oasis received medals at the 2025 High Spirits Awards, enhancing the brand's reputation and consumer appeal [4] Shareholder Engagement - The company prioritized preparations for its annual shareholder meeting and secured approval for the Series A Preferred conversion, which was critical for compliance with NYSE American standards [3][4]